Hyperkalemia (serum potassium> 5.5 mmol/L) may result from increased potassium intake,
impaired distribution between the intracellular and extracellular spaces, and/or reduced …

Abstract Hyperkalemia (serum potassium> 5.5 mEq/L) is a common clinical problem in
patients with chronic kidney disease, hypertension, diabetes, and heart failure. It can result …

For over 50 years, there have been limited options for the management of hyperkalemia,
especially among patients with chronic kidney disease (CKD), diabetic nephropathy …

Introduction: Hyperkalemia is a serious medical condition that often manifests in patients
with chronic kidney disease and heart failure. Renin–angiotensin–aldosterone system …

Objective: Recurrent hyperkalemia frequently limits use of renin–angiotensin–aldosterone
system inhibitors (RAASi) in chronic kidney disease (CKD) patients with hypertension …

Hyperkalemia is a serious and common clinical condition associated with increased
morbidity and death. The risk of hyperkalemia is increased in patients with chronic kidney …

Importance Hyperkalemia is a potentially life-threatening condition predominantly seen in
patients treated with renin-angiotensin-aldosterone system (RAAS) inhibitors with stage 3 or …

Maintaining potassium balance in the body is essential for cellular function. Even a slight
increase in normal serum potassium levels (3.5-5.0 mEq/L) can interfere with metabolism …

Hyperkalemia is a potentially life-threatening condition, and patients who have chronic
kidney disease, who are diabetic, or who are taking renin–angiotensin–aldosterone system …

Introduction: Hyperkalemia is a frequent electrolyte disorder associated with life-threatening
cardiac arrhythmias and sudden death. Patients prone to hyperkalemia have chronic kidney …